Obesity Is Not Associated with Impaired Immune Response to Influenza Vaccination in HIV-Infected Persons
Open Access
- 12 October 2015
- journal article
- research article
- Published by Wiley in AIDS Research and Treatment
- Vol. 2015, 1-7
Abstract
Introduction. HIV-infected individuals demonstrate lower immunogenicity to the influenza vaccine, despite immunologic and virologic control of HIV infection. Obesity has been previously shown to be associated with diminished antibody responses to other vaccines in HIV-uninfected persons. However, no studies have examined if obesity is associated with diminished protective immune response to influenza vaccination among HIV-infected persons on antiretroviral therapy (ART).Methods. We performed a retrospective analysis of immunogenicity data from a clinical trial of inactivated, trivalent influenza vaccine. The primary endpoint was the proportion of participants with seroconversion, defined as >4-fold increase in anti-hemagglutinin antibody titers after vaccination. Secondary endpoints were the proportion of participants with seroprotection (defined as antibody titers of ≥1 : 40) and geometric mean hemagglutination inhibition antibody titers.Results. Overall, 48 (27%) participants were obese (body mass index ≥ 30 kg/m2). Seroconversion rates were comparable between obese and nonobese subjects for all three vaccine strains. Further, postvaccination geometric mean titers did not differ by body mass index category.Conclusion. Obesity was not associated with diminished antibody response to influenza vaccination in a sample of healthy HIV-infected persons.Keywords
Funding Information
- National Institutes of Health (T32-AI-055435, UMI-AI069534-08)
- National Institutes of Health (T32-AI-055435, UMI-AI069534-08)
This publication has 35 references indexed in Scilit:
- High prevalence of obesity among women who enrolled in HIV prevention trials in KwaZulu-Natal, South Africa: healthy diet and life style messages should be integrated into HIV prevention programsBMC Public Health, 2013
- Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individualsBMC Immunology, 2012
- Obesity is associated with impaired immune response to influenza vaccination in humansInternational Journal of Obesity, 2011
- Obesity and Respiratory Hospitalizations During Influenza Seasons in Ontario, Canada: A Cohort StudyClinical Infectious Diseases, 2011
- Hypertension and Obesity as Cardiovascular Risk Factors among HIV Seropositive Patients in Western KenyaPLOS ONE, 2011
- Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled AnalysisPLOS Medicine, 2011
- Morbid Obesity as a Risk Factor for Hospitalization and Death Due to 2009 Pandemic Influenza A(H1N1) DiseasePLOS ONE, 2010
- Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responsesThe Lancet Infectious Diseases, 2009
- Obesity among Patients with HIV: The Latest EpidemicAIDS Patient Care and STDs, 2008
- Antiretroviral Therapies Associated with Lipoatrophy in HIV-Infected WomenAIDS Patient Care and STDs, 2007